Indeed, quantification of the solid tumour tissue and oedema revealed a significantly slower growth rate of the NG2 negative tumours, with mean volumes approximately 25% of those of NG2 positive tumours (Fig. 1D). The gene discussed is CSPG4; the disease is neoplasm.